Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 19, Number 9—September 2013

Research

Use of Staged Molecular Analysis to Determine Causes of Unexplained Central Nervous System Infections

Chien-Chin HsuComments to Author , Rafal Tokarz, Thomas Briese, Hung-Chin Tsai, Phenix-Lan Quan, and W. Ian Lipkin
Author affiliations: Columbia University, New York, New York, USA (C.-C. Hsu, R. Tokarz, T. Briese, P.-L. Quan, W.I. Lipkin); Southern Taiwan University of Science and Technology, Tainan, Taiwan (C.-C. Hsu); Chi-Mei Medical Center, Tainan (C.-C. Hsu); National Yang-Ming University Kaohsiung, Taiwan (H.-C. Tsai); Kaohsiung Veterans General Hospital, Kaohsiung (H.-C. Tsai)

Main Article

Table 4

EBV antibody in CSF and serum of patients identified with EBV infections by MassTag PCR*

Case CSF
Serum
VCA IgM VCA IgG EBV EA EBV NA VCA IgM VCA IgG EBV EA EBV NA
1 + +
2 + +
3 ND ND ND ND
4 + ND ND ND ND
5 + + + ND ND ND ND
6 + + +
7 + + +
8 + ND ND ND ND
9 + ND ND ND ND
10 + + +
11 + +
12 + + +
13 + ND ND ND ND
14 + ND ND ND ND
15 + ND ND ND ND
16 + +

*EBV antibody was measured by using commercial kit Euroimmun (Medizinische Labordiagnostika, Lübeck, Germany). Results were evaluated semiquantitatively by calculating a ratio of the extinction value of the control or patient samples over the extinction value of calibrator. Ratio <0.8: negative; ratio >1.1: positive. EBV, Epstein-Barr virus; CSF, cerebrospinal fluid; VCA, viral capsid antigen; EBV NA, EBV nuclear antigen indicating past EBV infections; EBV EA, EBV early antigen, indicating current or recent EBV infection; –, negative; +, positive; ND, not done.

Main Article

TOP